BOSTON, Jan. 20 (UPI) -- The roster of donors for a non-profit institute honoring Sen. Ted Kennedy, D-Mass., is ripe with major medical companies, The Boston Globe said Tuesday.
The newspaper said biotech pharmaceutical giant Amgen is the leading contributor to the Edward M. Kennedy Institute for the United States Senate, a fledgling educational non-profit planned for a site in Boston.
Amgen is joined by other healthcare heavyweights such as the Dana-Farber Cancer Institute and Partners Healthcare. The Globe said Kennedy has wielded significant influence over healthcare policy and federal research funding over the years.
Leaders of the fundraising effort told the Globe that everything they have been doing has been legal and that they stress transparency.